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Abstract (250 word limit) = 255 words 
Aims. To investigate the prevalence of awareness of the online illicit drug marketplace Silk Road 
(SR), consumption of drugs purchased from SR, and reasons for use and non-use of SR. Design 
and Setting. Global Drug Survey: purposive sample collected in late 2012. Participants. The base 
sample (N=9,470) reported recent drug purchase and resided in the UK (n=4315, median age 24, 
76% male), Australia (n=2761, median age 32, 76% male), or the USA (n=2394, median age 21, 
80% male). Measurements. Online questionnaire. Findings. 65% of USA, 53% of Australia, and 
40% of UK respondents had heard of SR. 18% of USA, 10% of UK, and 7% of Australian 
respondents had consumed drugs purchased through SR. Across the three countries, MDMA was 
the most commonly purchased drug (53-60%), followed by cannabis (34-51%), LSD (29-45%) 
and the 2C family (16%-27%). The most common reasons for purchasing from SR were wider 
range (75-89%), better quality (72-77%), greater convenience (67-69%), and the use of vendor 
rating systems (60-65%). The most common reasons for avoiding SR purchase were adequate 
drug access (63-68%) and fear of being caught (41-53%). Logistic regressions found that 
compared with people from Britain, Australians (OR=3.37; CI:2.29,4.97) and Americans (1.46; 
1.10,1.94) were more likely to use SR due to lower prices; and to avoid SR purchase due to fear 
of being caught (Australia: 1.65; 1.39,1.96; USA: 1.62; 1.37,1.92). Conclusions. While reasons 
for Silk Road use accord with broader online commerce trends (range, quality, convenience, 
ratings), its appeal to drug purchasers is moderated by country-specific deterrents and market 
characteristics.  
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1. INTRODUCTION 
From February 2011 (1) to October 2013 (2), the online illicit marketplace Silk Road (SR) 
enabled the international trade of illegal drugs and other goods and services (3-9). Online illicit 
marketplaces  or  ‘cryptomarkets’  (7) are located  in  the  ‘deep web’  and accessed via Tor (10). In 
the deep web, site owners, vendors and buyers are able to remain relatively anonymous as their 
IP addresses are masked. Purchases are made using the decentralised virtual currency Bitcoin 
(11), which can also be used relatively anonymously. 
In October 2013, the US Federal Bureau of Investigation (FBI) shut down the original SR and 
arrested its alleged founder (2). In their criminal complaint, the FBI, who had infiltrated the SR 
servers, outlined the scale of its operation over its 2.5-year  lifetime:  “several  thousand  drug  
dealers”  distributed  “hundreds  of  kilograms  of  illegal  drugs…  to  well  over  a  hundred  thousand  
buyers”  generating  sales  revenue equivalent to USD $1.2 billion in sales and USD $80 million in 
commissions (12, p. 6). Despite this event indicating that encryption technologies relied upon by 
cryptomarkets may have serious security weaknesses (13), a new SR was launched in November 
2013 (14) and  is  currently  expanding  its  operations  (author’s  observations,  November  2013). 
While not the only drug cryptomarket, the original SR was the largest and most well-known. We 
first described the marketplace within the academic literature (6), and since then, it has been 
explored through analyses of publicly available marketplace data (7-9), and qualitative online 
interviews with both buyers (3, 5) and vendors (4). SR has also been used as a tool for drug trend 
monitoring (15-17).  
In this paper, we extend this research by presenting results from a quantitative analysis of 
international survey data from a purposive sample of drug purchasers. We describe the A
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prevalence of awareness of SR, and consumption of drugs purchased from SR; demographic 
characteristics; drug types consumed; and reasons for use and non-use of SR. As our survey was 
conducted in 2012, our analyses refer to use of the original SR marketplace.  
2. METHODS 
2.1 Design 
An anonymous, annual online survey of drug use was designed and conducted by Global Drug 
Survey (GDS). A total of 22,289 responses were received between 15 November 2012 and 2 
January 2013. The sample used in this paper was restricted to those who indicated that they 
usually bought their own amphetamine, cannabis, cocaine, MDMA, ketamine or mephedrone, or 
who  reported  buying  ‘legal  highs’  /  ‘research  chemicals’  or  any  drugs  online  in  the  last  12  
months (n=11,848). Without this restriction, alcohol-only and other non-drug-purchasers were 
asked why they did not use SR, which was usually because they did not normally buy illicit 
drugs and therefore had no need to utilise the site. The base sample was further restricted to 
comprise only respondents who resided in or used the currency of Australia (AU), United 
Kingdom (UK), or United States of America (USA) (n=9,470). These countries were chosen 
because the majority of vendor listings from drugs on SR come from English-speaking countries 
(8), SR is only available in the English language, the GDS survey was only available in English, 
and these three countries were the best represented in the overall GDS. Where country of origin 
was missing and a relevant currency was nominated (n=555, 5.9%), we recoded country of origin 
to UK where UK pound was nominated, Australia where AU dollar was nominated, and USA 
where US dollar was nominated.  A
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The survey was promoted in partnership with the dance music magazine Mixmag, the Guardian 
and Fairfax Media, and also distributed through Facebook, Twitter, the social news website 
Reddit, and drug discussion forums. GDS successfully engaged mainstream media partners in the 
UK and Australia, where 60% and 80% of respondents, respectively, reported hearing about the 
survey through mainstream media. With no core media partner in the USA, the majority of 
recruitment occurred through the social news website Reddit (50%). The sample is purposive, 
and should therefore not be seen as representative of drug purchasers more generally. Ethical 
approval was received from the Joint South London and Maudsley and Institute of Psychiatry 
NHS Research Ethics Committee. 
2.2 Measures  
We designed questions that were informed by ongoing digital ethnographic research of SR being 
conducted by MB, which has involved participating in online discussions and monitoring the 
marketplace. Based on these observations, predetermined responses were provided for questions 
about  why  drug  purchasers  did  or  did  not  consume  drugs  from  SR.  An  ‘other’  field  was  also  
provided but was only used by up to 10% of respondents, indicating that the predetermined 
responses  were  relatively  adequate.  Question  wording  can  be  found  at  the  ‘Internet  drug  access  
and  legals  highs’  section  of  https://www.globaldrugsurvey.com/mixmag2013/survey.php.  
Other variables we used included: age, sex, employment status (employed and/or studying vs 
neither), educational attainment (university degree vs no degree), frequency of clubbing 
(attending  nightclubs:  4+  times  per  annum  vs  less  often),  ethnicity  (‘White’  vs  ‘Other’),  sexual  
orientation (heterosexual vs other), and how they found out about the survey. A
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2.3 Analysis 
Due to the sensitive nature of the information collected, IP addresses were not collected and 
therefore it was impossible to eliminate multiple entries from the same IP address. The dataset 
was scanned for identical entries but none were found. We consider it unlikely that anyone 
would complete the survey more than once as this would entail large amounts of time (from 15 
minutes to 1 hour or more) for no obvious gain as there were no material incentives offered. 
Of the 14 variables reported, there was a median of 1.2% missing data (Interquartile range [IQR] 
0.7-2.2%, range 0.5-4.9%). Due to the relatively low level of missing data, we have used 
available-case analysis rather than imputing missing data. The gain of undertaking more complex 
imputation is not usually justified if the proportion of missing data is minimal (18). For 
multivariable analysis, variables were retained in the final model if the grouped effect of the 
variable was significant at alpha level of 0.10. 
Descriptive statistics are provided in this paper to provide a snapshot of respondents and 
responses. Unless statistical comparisons are undertaken, we have not included p values or 
confidence intervals (CIs) for descriptive statistics. Notably, as the data presented here are drawn 
from a purposive sample, where we have reported 95% CIs for the estimates in our models, these 
should be interpreted with caution when generalising to broader populations. 
To compare differences between drug buyers, we created three outcome groups based on 
knowledge and utilisation of SR: (1) those who had never heard of SR, (2) those who had heard 
of, but never consumed drugs purchased from, SR, and (3) those who had consumed drugs 
purchased from SR. We used multinomial logistic regression (see equation 1) to compare 
differences between three countries – UK, Australia and USA – and users of SR first as an un-A
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adjusted analysis (no additional covariates) and then adjusted analysis adding additional 
covariates. We also compare reasons for why respondents had or had not consumed drugs 
purchased through SR. To undertake this analysis we used logistic regression for both unadjusted 
and adjusted models, which uses the same formula as presented in equation 1 however j* is the 
baseline  (‘no’  response)  category.   
 
Where  is the baseline category (never heard of SR), is a 
constant and  is a vector of regression coefficients for 
, for variables  
Equation 1 
 
The demographics of interest we adjusted for included age, sex, ethnicity, employment status, 
sexual orientation, educational attainment, and clubbing experience. Due to the skewed 
distribution of age we also included age as a squared term. For the multinomial logistic 
regression analyses, we present data for all covariates in the model. For the logistic regression 
analysis, we present results only for country differences, but list at the bottom of each model a 
list of the retained covariates. We retained covariates in the adjusted model if they were 
significant at an alpha level of 0.10. All analyses were conducted using Stata 12 (College Station, 
TX). 
3. RESULTS 
3.1 Exploring country differences 
Prevalence of SR awareness/purchase and demographic characteristics of the three samples are 
shown  in  Table  1.  Overall,  half  (50%)  the  sample  had  heard  of  ‘the  online  drug  marketplace  Silk  
Road’,  but  the  percentage  was  not  the  same  across  the  three  countries,  with  the  majority  in  the  A
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UK having not heard of SR compared around half of Australian respondents and a third of USA 
respondents. Of respondents who had heard of SR approximately one quarter of UK and USA 
respondents reported having consumed drugs purchased from SR while only 14 per cent of 
Australian respondents reported doing so. Of those who had consumed drugs purchased from 
SR, similar proportions across countries reported having purchased drugs themselves as opposed 
to having a friend purchase them on their behalf. 
Regarding demographics characteristics, the Australian sample was older (and somewhat more 
normally distributed) than either the UK or USA sample (see Supplementary Figure 1). This 
pattern may be an artefact of Fairfax Media being the primary recruitment tool in Australia. 
While the UK and USA samples were younger, the age distribution for these countries was 
greatly right-skewed. As shown in Table 1, both the UK and Australian sample were more likely 
to report employment and/or studying, and to have completed a university degree, compared 
with the USA sample. The UK sample was more likely to report attending nightclubs, likely 
reflecting the reach and readership of Mixmag, a UK dance music online and print publication, 
in recruitment. Distributions of sex, ethnicity, and sexual orientation were relatively similar 
between countries. 
Table 2 presents results of the multinomial logistic regression comparing country differences 
between respondents hearing about, and consuming drugs from, SR. The unadjusted model 
shows that, compared to respondents from the UK, the relative risk ratio (RRR) of hearing about, 
but not consuming drugs from SR, over not hearing of SR is greater for respondents from both 
Australia and the USA. In addition, the comparison between USA and Australia was also 
significant (RRR: 1.36; 95% CI: 1.21,1.53; p<0.001). The probability (and CI) of not hearing 
about SR for each of the three countries was: UK (0.60: 0.59,0.62), Australia (0.47: 0.45,0.49) A
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and USA (0.35: 0.33,0.37). By contrast, the probability of hearing about but not consuming 
drugs purchased from SR for each of the three countries was: UK (0.29: 0.28,0.31), Australia 
(0.46: 0.44,0.48) and USA (0.47: 0.45,0.49). 
Compared to respondents from the UK, the relative risk of hearing about, and consuming drugs 
from SR over not consuming drugs from SR, was significantly less for respondents from the 
Australia, but not different for respondents from USA. In addition, the comparison between USA 
and Australia was also significant (RRR: 2.44; 95% CI: 2.02,2.94; p<0.001). The probability of 
hearing about and consuming drugs purchased from SR for each of the three countries was: UK 
(0.10: 0.09,0.11), Australia (0.07: 0.06,0.82) and USA (0.18: 0.16,0.20). After adjusting for the 
covariates (presented in Table 2) the patterns seen with the unadjusted model remained with one 
exception. In the unadjusted model, compared to respondents from the UK, the RRR of hearing 
about, and consuming drugs from SR, over not hearing of SR, for Australian respondents, was 
not statistically different between the two countries. However, after adding the covariates to the 
model this now become statistically significant.  
3.2 What drugs were purchased on SR? 
Table 3 presents the top 20 drugs purchased from SR by country of residence. MDMA was the 
most commonly purchased drug. Over half of respondents, in each country, reported purchasing 
it, mainly in powdered (crystal) form. Cannabis was ranked in the top 4 drugs across countries 
and LSD in the top 5. Drugs from the 2C family were ranked in the top 6 to 8 across countries. 
Cocaine, amphetamines and NBOMe were ranked differently across countries. Cocaine was 
ranked 6th in Australia, while ranking 18th in the UK and outside of the top 20 for the USA. 
Similarly, amphetamines (including methamphetamine) was ranked 9th in Australia, 19th in the A
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UK and outside the top 20 for the USA. In contrast, NBOMe (all types) was ranked 5th in the 
USA, 10th in Australia and 13th in the UK.  
3.3 Why purchase from SR? 
We provided respondents with eight reasons for why they had consumed drugs purchased from 
SR (see Table 4). The top four reasons for purchasing from SR were in the same rank order 
across  countries  (with  percentages  presented  in  order  of  UK,  AU,  and  USA):  (1)  ‘SR  has  a  wider  
range  of  drugs  than  I  can  usually  access’  (77,  75,  89),  (2)  ‘SR  drugs  are  better  quality  than  I  can  
normally  acces’s  (72,  72,  77),  (3)  ‘It  is  more  convenient  to  order  drugs  online’  (69,  69,  67),  and  
(4)  ‘I feel more comfortable buying from sellers with high ratings’  (64,  60,  65).  Compared  to  
respondents from the UK, both Australian and USA respondents were significantly more likely 
to favour using SR due to lower prices and inadequate access to drugs through own networks 
(see Table 4). Moreover, compared to UK respondents, the respondents from the USA were 
more likely to report using SR due to access to a wider range of drugs and anonymity. No other 
statistically differences between each of the three countries were observed. 
Table 4 also presents adjusted odds ratios after taking into account the collection of covariates 
highlighted in Table 1. Overall, no new significant relationships were identified. However, the 
significant result in the unadjusted model, between Australia and UK for using SR due to better 
access to drugs, was lost; and the significant relationship between USA and UK for using SR as 
the prices were lower was weakened.  
3.4 Why not purchase from SR? 
Respondents who had heard of SR but had not purchased were asked for reasons why they had 
not yet purchased (Table 5). The most common response across all countries (with percentages A
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reported  in  order  of  UK,  AU,  and  USA)  was  ‘I have adequate access to drugs through my own 
networks’  (68,  63,  67)  and  the  next  most  common  response  was  ‘I fear being caught by 
police/customs if drugs are sent to my own address’  (41,  51,  53).  Compared  to  respondents  from  
the  UK,  both  Australian  and  USA  respondents  were  significantly  more  likely  to  favour  ‘fear  of  
being  caught’  as  a  reason  for  not  purchasing  drugs  from  SR.  There  was  no  significant  difference  
in the odds ratio between USA and Australia. Compared to respondents from the UK, USA 
respondents were significantly more likely not to use SR to buy drugs as they found accessing 
Bitcoins too difficult, were concerned about getting ripped off, thought prices for drugs on SR 
were too high and believed using SR to purchase drugs to be too much effort. By contrast, 
compared to UK respondents, Australian respondents were less likely to indicate accessing 
Bitcoins was difficult, less likely to consider SR prices as being too high, and less likely to 
indicate that accessing drugs via SR was too much effort. No other statistically differences 
between each of the three countries were observed. 
Table 5 also presents adjusted odds ratios accounting for the covariates highlighted in Table 1. 
The only new significant relationship identified was between respondents from the USA 
compared to UK respondents. USA respondents were significantly less likely to indicate that 
they  hadn’t  gotten  around  to  purchasing  drugs  from  SR.  However,  the  significant result in the 
unadjusted model, between Australia and UK for not using SR to purchase drugs because of the 
accessing Bitcoins was weakened, as was the difference between USA respondents compared to 
UK respondents in suggesting that SR prices are too high. The significant difference between 
Australian respondents and UK respondents in considering purchasing drugs from SR to be too 
much effort was lost after adjusting for significant covariates. A
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4. DISCUSSION 
This study is the first published description of a large global sample of drug users who were 
asked about their consumption of drugs purchased through an online drug marketplace. Data 
from the unadjusted model suggested that, in rank order, those respondents least likely to hear of 
SR were firstly from the UK, then Australia and then the USA. Furthermore, in rank order, those 
most likely to have consumed drugs from SR, were respondents from the USA, followed by the 
UK and then Australia. This pattern remained even after adjusting the model to account for age, 
sex, employment status, educational attainment, ethnicity, sexual orientation and clubbing 
behaviour. Across the three countries, MDMA was the most commonly purchased drug, 
followed by cannabis, LSD and the 2C family. Cocaine and amphetamine were more commonly 
purchased in Australia whereas the NBOMe family were more commonly reported in the USA. 
Globally, the most common reasons for purchasing from SR were wider range, better quality, 
greater convenience, and the use of vendor rating systems. Australians and Americans were more 
likely to be motivated by SR’s  lower  prices and by inadequate drug access through their own 
sources, compared with the British. Across countries, the most common reasons for not 
purchasing from SR were adequate drug access and fear of being caught. Australians and 
Americans were more likely to avoid SR purchase due to fear of being caught. Americans were 
more likely to be deterred from using SR by high prices, difficulty obtaining Bitcoin, and 
concern about getting ripped off.  
4.1 Fit with wider e-commerce trends 
Retailing and consumer research using large-scale surveys has explored the motivations of online 
shoppers and the predictors of satisfaction with the online shopping experience. Szymanski and 
Hise (19) produced a conceptual model of e-satisfaction which included convenience, quality A
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and variety of product offerings and product information, site design and financial security. 
Chiang and Dholakia (20) found that convenience and product type influenced intention to 
engage in online shopping. In this study, we found that the most commonly mentioned reasons 
for using SR to buy drugs fitted with wider e-commerce trends: access to a wider variety and 
better quality of product offerings, the convenience of online shopping, and access to more 
information about the products and the vendors/companies selling them. Further research is 
required to better understand how the use of this new way of accessing drugs occurs alongside 
other buying mechanisms, such as open street markets, network or social supply markets, and 
other online purchasing such as purchase of pharmaceuticals through websites, and the extent to 
which SR buyers engage in e-commerce more generally.  
4.2 Country specific differences 
Differences in the kinds of drugs bought from SR by country appear to reflect drug trends in 
those countries. For example, cocaine and amphetamines were more commonly purchased in 
Australia. Availability of cocaine through traditional markets in Australia is relatively low and 
prices relatively high (21), indicating an unmet demand which may explain the attraction of 
cocaine to Australian buyers. Australia has the highest prevalence of amphetamine use in the 
world (22), perhaps because of its relatively low access to cocaine. Regular amphetamine users 
in Australia may continue to seek this drug through SR. Also, emerging evidence from the USA 
(23-25) suggests that the NBOMe series is of growing concern in that country, a trend we see 
reflected in the current findings.  
After controlling for demographic differences, Australians and Americans were more likely to be 
motivated  by  SR’s  lower  prices  compared  with  the  British.  These  findings  accord  with  A
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Australian research which has compared SR prices with street market prices for common 
substances, finding that prices from international SR vendors were significantly less than street 
markets prices (15). Of those who did not purchase from SR, Australians and Americans were 
more likely to avoid SR purchase due to fear of being caught. These findings may reflect reduced 
perceptions of effective law enforcement activity in the UK, which may have more difficulty 
policing drugs through the post given its relatively porous borders with Europe, as well as 
prominent deterrence campaigns in Australia and the USA. 
4.3 Limitations 
The main limitation of this study is the non-representative sampling method. It is not possible to 
estimate the extent to which the samples, within each country, are representative of the general 
population in each country. Given the findings presented here, and the growing use of 
cryptomarkets to purchase drugs online, additional research is needed; ideally, research that has a 
probabilistic sampling design. Nevertheless, the method employed by Global Drug Survey has 
proved itself to be an effective way of accessing large drug using populations and identifying 
new drugs trends ahead of their penetration into the wider population (26-28). 
4.4 Conclusions 
Since these data were collected, the cryptomarket landscape has changed with the arrival of new 
drug marketplaces, the fall of the original SR, and the rise of the new SR. The speed of the 
marketplace’s  adjustment  to  the  FBI  seizure  of  SR  indicates  that  cryptomarkets  will  likely  
continue to expand, assuming they still provide utility and satisfaction to their target market. In 
this context, we need more detailed research from multiple perspectives to understand how this A
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new way of accessing drugs is affecting drug markets more broadly and how increased variety 
and availability of drugs affects drug use and harm profiles.  
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Table 1: Prevalence of SR awareness/purchase and selected demographics (%) [number missing] 
of full sample by country (n=9,470) 
SR use and demographics UK  
(n=4,315) 
Australia 
(n=2,761) 
USA  
(n=2,394) 
SR [41] [16] [14] 
Never heard of 60 47 35 
Heard of: Never consumed drugs 
purchased through SR 
29 46 47 
Heard of: Has consumed drugs 
purchased through SR 
10 7 18 
Self purchased  50  56  55  
Age (median – IQR) 24 (20–32) [42] 32 (25–41) [31] 21 (19–26) [37] 
Male 76 [171] 76 [197] 80 [100] 
Employed and/or studying 78 [40] 75 [31] 65 [35] 
Educational attainment: Degree 49 [73] 54 [59] 37 [78] 
Ethnicity:  ‘White’ 93 [55] 92 [35] 86 [39] 
Sexual orientation: Heterosexual 81[47] 78 [37] 79 [38] 
Clubbing: 4+ times per annum 66 [106] 39 [81] 36 [83] 
Note. Base sample = Respondents who usually buy their own drugs (including ‘legal highs’).  
 
A
cc
ep
te
d 
A
rti
cl
e
This article is protected by copyright. All rights reserved. 
Table 2: Multinomial logistic regression for hearing about, and consuming drugs from, SR: Relative risk ratio (and 95% CIs) 
 
 Unadjusted Model (n=9,399) 
χ2(4)=522, p<0.001 
Adjusted Model (n=8,597) 
χ2(18)=1260, p<0.001 
 Not Heard of vs. 
Heard of:  
Not Consumed 
Not Heard of vs. 
Heard of:  
Consumed 
Heard of: Not 
Consumed vs. 
Consumed 
Not Heard of vs. 
Heard of:  
Not Consumed 
Not Heard of vs. 
Heard of:  
Consumed 
Heard of: Not 
Consumed vs. 
Consumed 
UK 1.00 1.00 1.00 1.00 1.00 1.00 
Australia 2.02 (1.82,2.24)c 0.93 (0.77,1.11) 0.45 (0.38,0.55)c 2.35 (2.10,2.65)c 1.69 (1.38,2.07)c 0.72 (0.58,0.88)b 
USA 2.75 (2.46,3.07)c 3.07 (2.63,3.59)c 1.12 (0.96,1.31) 2.39 (2.11,2.70)c 2.62 (2.19,3.13)c 1.09 (0.92.1.31) 
Age 
(in 5 years) 
   0.71 (0.63,0.81)c 0.44 (0.34,0.57)c 0.62 (0.48,0.80)c 
Age2 
(in 5 years) 
   1.01 (1.00,1.02)c 1.03 (1.01,1.02)b 1.02 (1.00,1.04) 
Male    2.46 (2.18,2.77)c 3.17 (2.58,3.91)c 1.29 (1.04,1,61)a 
Degree    0.89 (0.80,0.98) 0.87 (0.74,1.02) 0.98 (0.83,1.15) 
‘White’    1.16 (0.98,1.37) 1.35 (1.04,1.74)a 1.17 (0.90,1.46) 
Heterosexual    0.91 (0.81,1.03) 0.83 (0.69,1.00)a 0.91 (0.76,1.09) 
Clubber    0.79 (0.71,0.87)c 1.08 (0.92,1.27) 1.37 (1.17,1.61)c 
Employed and/or studying – removed as not significant (χ2(2)=1.26; p=0.534). 
a p<0.05; b p<0.01; c p<0.001 
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Table 3: Top 20 drugs purchased from SR by country of residence (n=1036) 
 
Rank UK (n=422)  Australia (n=193)  USA (n=421)  
Drug % Drug % Drug % 
1 MDMA (All) 56 MDMA (All) 60 MDMA (All) 53 
2 Cannabis (All) 51 MDMA powder  47 MDMA powder  45 
3 MDMA powder  43 Cannabis (All) 34 LSD  45 
4 Cannabis Skunk  39 LSD  33 Cannabis (All) 34 
5 LSD  29 MDMA pills  27 NBOMe (All) 29 
6 Cannabis Resin  29 Cocaine  25 2C (All) 27 
7 MDMA pills  29 Cannabis Skunk  24 Magic Mushrooms  27 
8 2C (All) 23 2C (All) 16 Cannabis Skunk 24 
9 2C-B  22 Amphetamine (All) 16 DMT  24 
10 Cannabis Grass  21 NBOMe (All) 15 25I-NBOMe  22 
11 Prescription drugs (All) 18 Prescription drugs (All) 15 MDMA pills  21 
12 Ketamine  17 DMT  15 Prescription drugs (All) 20 
13 NBOMe (All) 13 Cannabis Grass  14 2C-B  18 
14 DMT  11 2C-B  13 Cannabis Resin  17 
15 25I-NBOMe  11 Magic Mushrooms  13 25C-NBOMe  16 
16 Benzodiazepines  10 Amphetamine  13 Ketamine  15 
17 Magic Mushrooms  9 25I-NBOMe  12 Benzodiazepines  12 
18 Cocaine  9 Ketamine  9 Methoxetamine  11 
19 Amphetamine (All) 9 25C-NBOMe  9 2C-E  11 
20 Amphetamine  9 Benzodiazepines  9 Cannabis Grass  10 
Note. Base sample = Respondents who usually buy their own drugs (including ‘legal highs’) and 
report having consumed drugs that were purchased through SR (n=1060; missing=24; sample for 
analysis=1036). Definition of composite variables: MDMA (All) = MDMA powder or MDMA 
pills. Cannabis (All) = Cannabis Skunk or Cannabis Grass or Cannabis Resin or Cannabis Oil. 
NBOMe (All) = 25I-NBOMe or 25C-NBOMe or 25B-NBOMe. Prescription drugs (All) = 
Benzodiazepines or Opioid pain killers or Dexamphetamine or Ritalin or Viagra or 
Buprenorphine or Etizolam or Methadone or Zopliclone or Modafinil or Tramadol. 
Amphetamine (All) = Amphetamine or Methamphetamine. 2C (All) = 2C-C or 2C-D or 2C-T-7 
or 2C-B or 2C-E or 2C-I or 2C-P.  
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Table 4: Logistic regressions predicting reasons for using SR (n=1060) 
 
Reasons for use 
Unadjusted Odds 
Ratios 
Adjusted Odds 
Ratios 
OR OR* 
SR prices are lower (n=1060) (n=1044) 
UK 1.00 1.00 
Australia 2.14 (1.52,3.02)c 3.37 (2.29,4.97)c 
USA 1.63 (1.24,2.14)c 1.46 (1.10,1.94)b 
* retained covariates: age, age2, heterosexual 
SR has a wider range of drugs than I can usually access (n=1060) (n=1001) 
UK 1.00 1.00 
Australia 0.91 (0.62,1.34) 1.08 (0.70,1.67) 
USA 2.37 (1.63,3.43)c 2.31 (1.56,3.44)c 
* retained covariates: age, sex, degree, workstudy 
It is more convenient to order drugs online (n=1060) (n=1060) 
UK 1.00 1.00 
Australia 1.04 (0.72,1.49) 1.04 (0.72,1.49) 
USA 0.93 (0.70,1.23) 0.93 (0.70,1.23) 
* retained covariates: nil  
I want to avoid physically meeting with drug dealers (n=1060) (n=1001) 
UK 1.00 1.00 
Australia 1.24 (0.88,1.73) 0.92 (0.63,1.34) 
USA 0.89 (0.68,1.16) 0.80 (0.60,1.08) 
* retained covariates: age, age2, sex, heterosexual, clubber 
SR drugs are better quality than I can usually access (n=1060) (n=1030) 
UK 1.00 1.00 
Australia 1.03 (0.71,1.49) 1.34 (0.89,2.03) 
USA 1.34 (0.99,1.82) 1.26 (0.90,1.76) 
* retained covariates: age, heterosexual, clubber, workstudy 
I feel more comfortable buying from sellers with high ratings (n=1060) (n=993) 
UK 1.00 1.00 
Australia 0.86 (0.61,1.21) 0.76 (0.53,1.10) 
USA 1.09 (0.83,1.45) 0.94 (0.70,1.27) 
* retained covariates: sex, degree, clubber   
I don’t have adequate access to drugs through my own networks (n=1060) (n=1035) 
UK 1.00 1.00 
Australia 1.86 (1.32,2.62)c 1.44 (1.00,2.08) 
USA 2.12 (1.61,2.79)c 1.90 (1.41,2.54)c A
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* retained covariates: age, clubber   
It is more anonymous to buy through SR (n=1060) (n=1034) 
UK 1.00 1.00 
Australia 1.31 (0.94,1.83) 1.18 (0.83,1.67) 
USA 1.57 (1.20,2.06)b 1.38 (1.04,1.83)b 
* retained covariates: heterosexual, clubber 
Note. Base sample = Respondents who usually buy their own drugs (including ‘legal highs’) and 
report having consumed drugs that were purchased through SR (n=1060; missing=53; sample for 
analysis=1007). Dependent variable = respondent reports this statement as a reason they or 
someone on their behalf purchased drugs through SR.  
* Covariates retained had a p-value less than 0.10. 
See Table 1 for definitions of covariates.  
a p<0.05; b p<0.01; c p<0.001 
 
A
cc
ep
te
d 
A
rti
cl
e
This article is protected by copyright. All rights reserved. 
 
Table 5: Logistic regressions predicting reasons for not using SR (n=3445) 
 
Reasons for not using 
Unadjusted Odds 
Ratios 
Adjusted Odds 
Ratios 
OR OR* 
I have adequate access to drugs through my own networks (n=3634) (n=3484) 
UK 1.00 1.00 
Australia 0.83 (0.70,0.97) 0.85 (0.71,1.01) 
USA 0.96 (0.81,1.14) 1.06 (0.88,1.27) 
* retained covariates: age, degree, clubber 
I fear being caught by police/customs if drugs are sent to my 
own address (n=3634) (n=3599) 
UK 1.00 1.00 
Australia 1.50 (1.28,1.75)c 1.65 (1.39,1.96)c 
USA 1.67 (1.42,1.96)c 1.62 (1.37,1.92)c 
* retained covariates: age, age2 
Bitcoins are too difficult to get (n=3634) (n=3442) 
UK 1.00 1.00 
Australia 0.53 (0.43,0.65)c 0.72 (0.57,0.90)b 
USA 1.69 (1.41,2.02)c 1.53 (1.27,1.85)c 
* retained covariates: age, age2, sex  
I am concerned about getting ripped off (n=3634) (n=3599) 
UK 1.00 1.00 
Australia 0.96 (0.80,1.15) 0.96 (0.79,1.17) 
USA 1.42 (1.19,1.70)c 1.44 (1.20,1.73)c 
* retained covariates: age, age2 
I don’t understand the technologies well enough (n=3634) (n=3392) 
UK 1.00 1.00 
Australia 0.88 (0.71,1.07) 0.97 (0.77,1.21) 
USA 0.97 (0.79,1.19) 0.97 (0.78,1.20) 
* retained covariates: age, sex, degree 
SR prices are too high (n=3634) (n=3530) 
UK 1.00 1.00 
Australia 0.29 (0.20,0.43)c 0.32 (0.21,0.47)c 
USA 1.71 (1.33,2.20)c 1.49 (1.13,1.97)b 
* retained covariates: age, clubber   
Buying on SR is too much effort (n=3634) (n=3599) 
UK 1.00 1.00 
Australia 0.65 (0.54,0.79)c 0.92 (0.75,1.12) A
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USA 1.46 (1.22,1.73)c 1.27 (1.06,1.52)c 
* retained covariates: age   
No  reason,  I  just  haven’t  gotten  around  to  it (n=3634) (n=3382) 
UK 1.00 1.00 
Australia 0.94 (0.78,1.12) 0.95 (0.79,1.15) 
USA 0.86 (0.72,1.04) 0.81 (0.67,0.99)a 
* retained covariates: sex, degree, white 
Note. Base sample = Respondents who usually buy their own drugs (including ‘legal highs’) and 
have heard of the SR, but have not bought drugs from SR. 
Dependent variable = respondent reports this statement as a reason they have not purchased 
drugs through SR.  
* Covariates retained had a p-value less than 0.10. 
See Table 1 for definitions of covariates.  
a p<0.05; b p<0.01; c p<0.001 
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